Biodegradable IR-1061 Nanoparticles for Deep NIR-II In Vivo Imaging

Study Background and Research Question

Near-infrared (NIR) fluorescence bioimaging has emerged as a powerful approach in biomedical research, offering enhanced tissue penetration and reduced phototoxicity compared to conventional ultraviolet (UV) and visible light imaging. However, most existing fluorescent probes suffer from inadequate tissue penetration and significant background noise, limiting their effectiveness in deep tissue imaging. The second biological window (NIR-II, 1000–1350 nm), part of the broader OTN-NIR (over-1000 nm near-infrared) range, has received particular interest due to its ability to further minimize scattering and autofluorescence, thus enabling clearer imaging of deeper anatomical structures. Despite these advantages, the field has lacked safe, easily prepared, and biocompatible fluorescent dye systems for in vivo use, as highlighted in the reference study and corroborated by other recent literature.

Key Innovation from the Reference Study

The study presented a significant advance by developing a biodegradable polymer nanoparticle system encapsulating the organic near infrared fluorescent dye IR-1061 for deep tissue in vivo imaging in the NIR-II window. Unlike commonly used inorganic nanomaterials, such as quantum dots or rare earth-doped nanoparticles, this approach leverages commercially available, biocompatible amphiphilic block copolymers (PEG-b-PCL) to create nanoparticles capable of efficient NIR-II emission without the toxicity or regulatory barriers associated with metals or ceramics. The encapsulation of IR-1061 in the hydrophobic core of PEG-b-PCL micelles enables stable aqueous dispersion and deep-tissue fluorescence, addressing a longstanding challenge with hydrophobic small-molecule dyes.

Methods and Experimental Design Insights

The researchers used a straightforward 'one-pot' self-assembly procedure to encapsulate IR-1061 within PEG-b-PCL micelles. This method takes advantage of the amphiphilic nature of PEG-b-PCL, which spontaneously forms micelles in aqueous environments: the hydrophobic poly(ε-caprolactone) (PCL) segment forms the core, sequestering the hydrophobic IR-1061, while the hydrophilic poly(ethylene glycol) (PEG) shell ensures water solubility and biocompatibility. Notably, the nanoparticle size can be tuned within the optimal 10–100 nm range for prolonged blood circulation and tumor accumulation via the enhanced permeability and retention (EPR) effect, as discussed in the reference study. The entire process is considerably less complex than previous multi-step, layer-by-layer assembly methods, making the technology accessible to a wide range of biomedical laboratories.

Protocol Parameters

• Polymer selection: Use commercially available PEG-b-PCL block copolymers for biocompatible and biodegradable micelle formation.
• Dye encapsulation: Dissolve IR-1061 in an organic solvent (e.g., DMSO) at concentrations compatible with micelle formation; add to aqueous PEG-b-PCL solution under stirring to induce self-assembly.
• Particle sizing: Tune the polymer-to-dye ratio and assembly conditions to achieve nanoparticles in the 10–100 nm range, balancing circulation half-life and tissue penetration.
• Storage and handling: Prepare nanoparticles freshly; avoid long-term storage of IR-1061 solutions, as recommended in product information.

Core Findings and Why They Matter

The primary result of the study was the successful creation of IR-1061-loaded PEG-b-PCL nanoparticles (OTN-PNPs) that retained strong NIR-II fluorescence in aqueous environments. These nanoparticles demonstrated excellent stability, high signal-to-background imaging capability, and efficient passive tumor targeting in vivo. The use of biodegradable polymers enabled subsequent renal clearance, reducing long-term toxicity concerns associated with persistent inorganic nanomaterials. Importantly, the adoption of a simple preparation workflow broadens accessibility, eliminating the need for advanced synthetic chemistry skills. Together, these innovations allow for safer, more practical deep tissue optical imaging in preclinical models, supporting applications in oncological research and drug delivery studies.

Comparison with Existing Internal Articles

Recent internal articles have highlighted complementary strategies for deploying IR-1061 as a near infrared fluorescent dye in biomedical research. For instance, Yu et al. demonstrated that H-aggregation of IR-1061 within lipid or peptide-coated nanosystems can synergistically enhance both NIR-II fluorescence imaging and photothermal therapy, offering multifunctional tumor targeting and therapy (see here). Another study systematically optimized IR-1061-loaded liposomal charge and concentration for vascular imaging, emphasizing the importance of nanoparticle surface chemistry in tuning imaging performance (details). Compared to these approaches, the reference study's innovation lies in its use of a fully biodegradable polymer carrier and a highly streamlined, one-pot assembly process, prioritizing clinical translatability and ease of use while maintaining robust imaging performance. These developments collectively underscore the versatility of IR-1061 as a fluorescent dye for molecular imaging, adaptable to multiple nanoscale delivery platforms.

Limitations and Transferability

While the PEG-b-PCL/IR-1061 system offers several advantages over inorganic and multi-component nanomaterials, certain limitations remain. The encapsulation efficiency and quantum yield of IR-1061 within polymer micelles may require further optimization for specific applications, and the in vivo clearance kinetics can vary depending on the nanoparticle size and surface modifications. Additionally, although the one-pot preparation is less technically demanding, researchers must still validate batch-to-batch reproducibility and scale-up for translational studies. The technology is primarily validated in small animal models; its transferability to larger models or clinical settings will necessitate further safety and pharmacokinetic studies. Nonetheless, the study provides a clear framework for developing practical, biocompatible NIR-II imaging probes for biomedical research.

Research Support Resources

Researchers aiming to replicate or extend these protocols can source high-purity IR-1061 (SKU C8242) for in vivo NIR-II imaging experiments. IR-1061 is a near infrared fluorescent dye characterized by strong OTN-NIR emission, high solubility in DMSO, and well-validated quality controls. For optimal results, follow recommended handling and storage procedures, and consider integrating IR-1061 into biodegradable polymer carriers such as PEG-b-PCL to enable aqueous stability and biocompatibility in deep tissue imaging workflows. This approach aligns with the protocols and findings described in the reference study and related recent literature.